# Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2026

- Company: [Alterity Therapeutics Ltd](/companies/athe.md) (CIK 1131343)
- Form: 20-F
- Filed: 2026-08-28
- Accepted by EDGAR: Aug 28, 2026, 09:14 ET
- Period: 2026-06-30
- Accession: 0001437749-26-029135
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131343/000143774926029135/athe20260630_20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131343/000143774926029135/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2026-06-30 | 217,508,862 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131343/000143774926029135/athe20260630_20f.htm

Filed Aug 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-029135. Last ingested by Listed: Nov 12, 2026, 17:12 ET. No prices; not investment advice.
